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Molecular mechanisms for cell migration, especially how signaling and cytoskeletal systems are integrated, are not
understood well. Here, we examined the role of CARMIL (capping protein, Arp2/3, and Myosin-I linker) family proteins
in migrating cells. Vertebrates express three conserved genes for CARMIL, and we examined the functions of the two
CARMIL genes expressed in migrating human cultured cells. Both isoforms, CARMIL1 and 2, were necessary for cell
migration, but for different reasons. CARMIL1 localized to lamellipodia and macropinosomes, and loss of its function
caused loss of lamellipodial actin, along with defects in protrusion, ruffling, and macropinocytosis. CARMIL1-knockdown cells showed loss of activation of Rac1, and CARMIL1 was biochemically associated with the GEF Trio. CARMIL2,
in contrast, colocalized with vimentin intermediate filaments, and loss of its function caused a distinctive multipolar
phenotype. Loss of CARMIL2 also caused decreased levels of myosin-IIB, which may contribute to the polarity phenotype. Expression of one CARMIL isoform was not able to rescue the knockdown phenotypes of the other. Thus, the two
isoforms are both important for cell migration, but they have distinct functions.

INTRODUCTION
Cell migration is an essential element of many aspects of
animal cell biology, such as morphogenesis during development, immune response to disease, and chemotaxis (Ridley
et al., 2003; Vicente-Manzanares et al., 2005). In some settings,
cell migration is a prominent component of disease, involved in the progression of malignant cancers and autoimmune syndromes. Cell migration requires proper function of
the cytoskeleton, with integration of the actin and microtubule and intermediate filament cytoskeletons.
A migrating cell is generally polarized with broad actinrich lamellipodia at its leading edge. Lamellipodia contain
dense meshworks of actin filaments with their fast-growing,
barbed ends of actin filaments oriented toward the direction
of migration, and polymerization at barbed ends provides
the driving force pushing the plasma membrane forward (Le
Clainche and Carlier, 2008). Protrusions at the leading edge
also include long thin structures termed filopodia or microspikes, which are composed of bundles of actin filaments
that often appear to arise from the lamellipodial actin network (Svitkina et al., 2003). Lamellipodia are often accompanied by ruffles, which are wave-like structures that form
by protruding upward and then moving rearward, sometimes resulting in macropinocytotic engulfment of extracellular fluid. The actin network of the leading edge contains
many proteins, including Arp2/3 complex, cofilin, and capping protein (CP). In vitro, a synthetic mix of these proteins
can form branched networks of filaments, and the assembly
of those networks can produce movement (Pollard, 2007).
The structure, molecular nature, and dynamics of these network in cells is not understood well, with considerable
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controversy as to their assembly, function, and turnover
(Koestler et al., 2008; Lai et al., 2008).
Regulation of barbed ends, their creation and capping, is
considered to be a key element controlling the architecture
and force production of actin filament networks. Biochemically, free barbed ends can be created by nucleation from
actin subunits de novo, by uncapping capped ends or by
severing existing filaments. To create free barbed ends, the
dendritic nucleation model proposes that activated Arp2/3
complex binds to an existing mother filament, which nucleates the formation of a new daughter filament with a free
barbed end (Pollard, 2007). Other models propose that activation of cofilin to sever filaments is a primary event that
creates free barbed ends (van Rheenen et al., 2007) or that
inhibition of capping by proteins such as formins or Ena/
VASP is critical (Applewhite et al., 2007; Le Clainche and
Carlier, 2008).
In this study, we investigated how CARMIL family proteins function in cell migration. In particular, we compared
the functions of the human CARMIL1 and 2 proteins, which
are expressed together in many cells and tissues. In migrating cancer cells, we found both proteins to be important but
with distinct nonoverlapping roles. CARMIL2 controls cell
polarity and associates with vimentin intermediate filaments, whereas CARMIL1 controls actin dynamics in lamellipodia, possibly through regulation of Rac1 via interaction
with the guanine nucleotide exchange factor (GEF) Trio.
MATERIALS AND METHODS
Antibodies and Reagents
Reagents and materials were from Sigma-Aldrich (St. Louis, MO) or Fisher
Scientific (Pittsburgh, PA) unless stated otherwise.
For CP, mouse mAb 3F2 specific for the C-terminus of beta2 and 5B12
recognizing alpha1 and alpha2 were used for immunoblots as described
(Developmental Studies Hybridoma Bank, University of Iowa; Schafer et al.,
1996). Rabbit pAb R26 against the C-terminus of beta2 was used for immunostaining (Schafer et al., 1994). For CARMIL, chicken antibodies against a
fragment of human CARMIL1 (538 –1371) were produced by Dr. Ilgu Kang in
our lab. Other antibodies and sources were as follows: VASP (rabbit pAb)
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from Dr. Frank Gertler (MIT); Myosin 1E (rabbit pAb) from Drs. Mira Krendel
and Mark Mooseker (Yale University); ARPC2/p34 (rabbit pAb) and cortactin
(mouse mAb 4F11) from Upstate Millipore (Lake Placid, NY); VASP (rabbit,
pAb) from Calbiochem (La Jolla CA); giantin (rabbit, pAb) from Covance
(Madison, WI); Myosin-IIA and Myosin-II B (rabbit, pAbs) from Covance and
Dr. Paul Bridgman (Washington University); paxillin (mouse, mAb) from
BD Bioscience (San Jose, CA); Trio (goat pAb) from Biotechnology (Santa
Cruz, CA); and actin (mouse mAb C4), a gift from Dr. James Lessard
(University of Cincinnati). Antibodies to ␣-tubulin (mouse, mAb), acetylated tubulin (mouse, mAb), ␥-tubulin (mouse, mAb), and FLAG (mouse,
mAb) were from Sigma-Aldrich, as was FLAG M2 affinity beads. Antigreen fluorescent protein (GFP; rabbit, pAb), Dynabeads M-280 sheep
anti-rabbit IgG, and HRP- and Alexa-conjugated secondary antibodies
were from Invitrogen (Carlsbad, CA).

964, C2b 598-963, C3 594-954. CBR: C1 964-1078, C2b 964-1072, C3 955-1063.
C-terminal region: C1 1079-1371, C2b 1073-1372, C3 1064-1372. The acidic
regions are located between residues 878-889, 899-911, and 937-955 in C1,
874-905 and 929-945 in C2 and 889-903 in C3. The verprolin-like sequence
is located between residues 702-735 of C1, 705-738 in C2 and residues
700-733 of C3.

Cell Culture, Transfection, and Knockdown

Human total RNA was purified from HeLa cells using an RNeasy kit (QIAGEN,
Valencia, CA), and 30 ng was reverse-transcribed to first-strand cDNA using
Superscript (Invitrogen). Using this cDNA as template, PCR amplification with
specific primer pairs (Supplemental Table S1) produced cDNA clones for fulllength human CARMIL1 and 2.
For CARMIL1, the primers were chosen based on the National Center for
Biotechnology Information (NCBI) sequence NM_017640, extending from the
initiating ATG to the stop codon of the CDS. Several independent clones were
obtained, and their sequences agreed with that of NM_017640, except for an
insertion of 135 bases between 3906 and 3907. The sequence of the clones we
obtained was submitted to NCBI with accession number FJ009082. We refer to
this novel longer form as CARMIL1a and the shorter form, predicted by
NM_017640, as CARMIL1b. Our CARMIL1a cDNA was used for all experiments in this study.
For CARMIL2, primers were chosen based on NM_001013838, from initiating ATG to stop codon, which we call CARMIL2a. We obtained several
independent full-length ORF clones all corresponding to a slightly shorter
variant that we call CARMIL2b, and we made a new NCBI accession FJ026014
for this variant. In CARMIL2b, exon 37 is missing. Furthermore, the intronic
sequence between exons 14 and 15 in the RLTPR gene is not excised but is
translated in-frame. Variations such as these were among ones described
previously for partial clones (Matsuzaka et al., 2004). Our CARMIL2b fulllength ORF cDNA was used for all experiments in this study.
For expression and localization, the full-length cDNAs encoding
HsCARMIL1a and HsCARMIL2b were subcloned into the EcoRI/BamHI and
HindIII/SpeI sites of pEYFP-C1 (Clontech, Palo Alto, CA), respectively. To
express FLAG-tagged CARMIL fragments, the corresponding cDNA regions
of HsCARMIL1 and HsCARMIL2 were subcloned into pUHDF30 (Liang et al.,
2004). All constructs were sequenced fully.
To assay expression from cultured cell lines, 30 ng of total RNA was used
for first-strand cDNA synthesis with platinum Taq DNA polymerase (Invitrogen). ␤-Actin was used as an internal control. PCR amplification was performed with primers pairs listed in Supplemental Table S1.

Human HT-1080 cells (ATCC, Manassas, VA) and human embryonic kidney
HEK293T cells were grown in DMEM (GIBCO BRL, Rockville, MD) supplemented with 10% calf serum (GIBCO) in an atmosphere containing 5% CO2.
Cells were transfected with FuGENE6 (Roche, Indianapolis, IN) or Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. For
overexpression, cells were fixed 48 h after transfection.
To knock down human CARMIL1 and 2, we targeted the coding region
sequences ATGCCATTGTTCATCTGGAT and GCAAAGATGGCGAGATCAAG, respectively. BLAST searches against the human genome revealed no
other targets. A scrambled sequence, CAGTCGCGTTTGCGACTGG, was
used as a control. Pairs of complementary oligonucleotides were annealed
and inserted into an short hairpin RNA (shRNA)-expression vector, pSUPER,
according to the manufacturer’s instructions (OligoEngine, Seattle, WA). The
resulting plasmids were transfected into HT-1080 cells using Lipofectamine,
and cells were fixed or harvested at 48 –72 h after transfection. Red fluorescent
protein (RFP) or GFP-actin served as a cotransfection marker. To obtain a
knockdown-positive cell population, the target sequences were subcloned
into the plasmid pFLRu-FH-GFP (a gift from Dr. Yunfeng Feng in the
Longmore lab, Washington University). GFP-positive cells were sorted at
24 h after transfection and maintained in media with puromycin (3 g/ml)
for up to 1 wk. Phenotypes were analyzed on day 3– 4 after transfection.
For rescue by expression, site-directed mutagenesis was used to construct
a pFLRu-CARMIL1shRNA plasmid with three codon-neutral mutations
(GCC to GCT, GTT to GTG, and CTG to CTC), and a pFLRu-CARMIL2shRNA
plasmid with three codon-neutral mutations (AAA to AAG, GAT to GAC,
and GGC to GGG).
To knock down YFP-HsCARMIL1 or YFP-HsCARMIL2, HEK293 cells or
HT-1080 cells were cotransfected with plasmids expressing an shRNA,
YFP-HsCARMIL1, or YFP-HsCARMIL2 and mRFP using Lipofectamine.
Cells were processed 48 h after transfection for fluorescence microscopy. To
knockdown Arp2/3, an siRNA for human ArpC4 (p20), AAGGAGATCAGTGAGATGAAG, was used, with the scrambled sequence, CAGTCGCGTTTGCGACTGG, as control. HT-1080 cells were transfected with siRNA using
Lipofectamine2000 (Invitrogen), and cells were processed for immunoblot
and immunofluorescence at 72 h.
The vimentin-knockdown plasmid was a gift from Dr. Yunfeng Feng
(Washington University). The target sequence GGCACGTCTTGACCTTGAAC against human vimentin was subcloned into the plasmid pFLRu-FH.
Cells were transfected with pFLRu-Vimentin shRNA using Lipofectamine.
For YFP-CARMIL2 localization, YFP-CARMIL2 was introduced into cells
transfected with pFLRu-Vimentin shRNA 72 h after transfection.

Sequence Alignment and Phylogenetic Tree Analysis

Microscopy of Cells

An unrooted phylogenetic tree was generated from a multiple sequence
alignment of CARMIL family members. The sequences were retrieved
from NCBI with the following accession numbers: human1a FJ009082,
human2b FJ026014, human3 NP_612369, mouse1 NP_081101.3, mouse2
NP_001028492.1, mouse3 NP_001019816.1, rat1 XP_225336.4, rat3 Q5XHY1
(UniProt), stickleback ENSGACG00000006707 (ENSEMBL), Danio rerio
XP_684159.3, Anopheles gambiae XP_314353.3, Ades egypti AAEL000228-RA,
Drosophila melanogaster NP_610316.2, Dictyostelium XP_629656.1, Acanthamoeba
castellanii AAB57739, chimpanzee1 XP_511754, chimpanzee2 XP_523395.2,
chimpanzee3 XP_509860.2, dog1 XP_545371.2, dog2 XP_536814.2, dog3
Q8ND23 (UniProt), chicken1 XP_419088, chicken2 XP_414033, cow1
XP_617473, cow2 XP_587484.3, cow3 XP_595353.3, Caenorhabditis elegans
Q21301 (UniProt) and C. briggsae CAP37466.1, Tetraodon1 CAF93839, and
Apis mellifera XP_624410. The initial list of CARMIL family members was
obtained from the TREEFAM database (www.treefam.org) as family
TF316381. Each family member was verified by BLAST searching against
human CARMIL homologues. Only sequences containing a consensus CARMIL homology domain (CHD), a leucine-rich repeat (LRR) region, and a
CP-binding region (CBR) were included in the alignment. The multiple sequence alignment and unrooted phylogenetic tree were produced using
ClustalW (Larkin et al., 2007) and Njplot Unrooted (Saitou and Nei, 1987). The
reliability of the tree structure was tested by bootstrapping with 1000 trials.
All nodes on the tree were present in ⬎90% of the trials.
Sequence alignments for the CHD and CBR regions were made with
ClustalW and MegAlign (DNASTAR, Madison, WI), with database sequences
from NCBI as listed above. The percentage identities between various regions
of human CARMILs 1, 2, and 3 (listed here as C1, C2 and C3 for brevity) were
calculated using MegAlign. The boundaries of the regions were as follows:
N-terminus (start to CHD): C1 1-155, C2 1-154, C3 1-152. CHD: C1 156-181,
C2b 155-180, C3 153-178. LRR: C1 214-595, C2b 213-597, C3 211-593. Central
region containing putative verprolin-homology and acidic regions: C1 596-

Cells were plated onto glass coverslips coated with 30 g/ml fibronectin
(Sigma-Aldrich), fixed in paraformaldehyde or methanol, and processed as
described (Mejillano et al., 2004). Immunostaining was performed with appropriate antibodies. Free barbed ends in permeabilized cells were visualized
by addition of fluorescent actin, essentially as described (Bryce et al., 2005).
Cells were permeabilized and labeled with 0.4 M Alexa-568-actin (Molecular
Probes, Eugene, OR) in saponin buffer for 30 s and then fixed with 4%
paraformaldehyde. Cells were imaged with 10⫻ or 60⫻ objectives on an
Olympus IX70 inverted microscope (Olympus, Melville, NY) equipped with a
Coolsnap HQ camera (Photometrics, Woburn, MA). Images were collected
and initially process with QED In Vivo software (Media Cybernetics, Silver
Spring, MD). Images were converted to pseudocolor using Adobe Photoshop
(San Jose, CA). Polarity was scored by “blind” observers as described (Sidani
et al., 2007).
For wound-healing assays, shRNA-transfected cells were grown to a monolayer, serum-starved for 12 h, wounded with a pipette tip, and fed fresh
medium with 10% FBS. Cells were allowed to recover for 30 min, and then
time-lapse images were captured every 1.5 min for 2 h.
For time-lapse movies, cells were grown on glass-bottom culture dishes
(MatTek, Ashland, MA) coated with fibronectin (30 g/ml). Cells were
adapted to L-15 medium (Invitrogen) supplemented with 10% FBS (GIBCO)
at 37°C. For long-term movies, phase-contrast images were captured every 2
min for 2 h. For short-term movies, images were captured every 1 s for 5 min.
For cell spreading assays, trypsinized cells were seeded onto a glass-bottom
culture dish coated with fibronectin. After 1–5 min, images were captured
every 1 min for 30 min. For quantitative analysis of lamellipodial motility
parameters, phase-contrast time-lapse movies were viewed. Each experimental group contained at least 13 cells. Images were taken every second for 5
min. A cell with one or more broad lamellipodia or phase-dark ruffles was
scored as positive for lamellipodia or ruffles, respectively. A cell with no
obvious protrusion or having a smooth edge without protrusion and with-
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drawal was scored as a negative for lamellipodia or ruffles. Persistence was
defined as the continuous presence of protrusion or ruffling activity for 5 min.
Macropinocytosis was scored as positive if more than two macropinosomes
were observed during the time course of the movie. Two “blind” observers
evaluated the movies independently, and the data were quantified for each
parameter by averaging the percent of cells determined by each observer.
Two-tailed t statistical tests were performed for statistical analysis, and p ⬍
0.05 was considered significant.
Disassembly of vimentin filaments or microtubules. For withaferin A
(WFA) experiments, cells were treated with 0.5–10 M WFA (Chromadex,
Irvine, CA) from a stock solution in DMSO or the appropriate volume % of
DMSO as a control for 1 h and then fixed with 4% paraformaldehyde (Bargagna-Mohan et al., 2007). Nocodazole treatment was at 5 M for 60 min, with
a 60-min washout.

Coimmunoprecipitations and Immunoblots
Coimmunoprecipitation with anti-FLAG M2 affinity gel was performed as
described (Liang et al., 2004). Coimmunoprecipitation with anti-GFP (Invitrogen) was performed as instructed by the manufacturer. Briefly, cells were
lysed with 20 mM Tris/HCl, pH 7.5, 100 mM NaCl, 0.5% NP-40, 10% glycerol,
and protease cocktail inhibitor (Calbiochem). The lysates were centrifuged to
remove debris, and supernatants were incubated for 2 h at 4°C with Dynabeads precoated with anti-GFP antibody. Beads were washed three times with
lysis buffer, boiled with 2⫻ SDS loading buffer, and then subjected to SDSPAGE, followed by immunoblotting. For the Rac1 activity assay, 2 ⫻ 106 cells
were allowed to adhere to fibronectin-coated culture dishes for 0, 15, and 30
min. The Rac1 activity was measured by pulling down with PAK-PBD as
described by the manufacturer (Upstate). Immunoblots were developed with
ECL (Perkin Elmer-Cetus, Boston, MA) and exposed to autoradiography film.

RESULTS
The CARMIL Protein Family: Cloning, Phylogeny, and
Expression
To study CARMIL function, we first asked how many forms
of CARMIL exist in mammalian systems. Early after the
discovery of CARMIL in Acanthamoeba as Acan125, a C.
elegans gene predicted to encode a protein of similar sequence was identified (Xu et al., 1997). A Dictyostelium protein, p116, was then found to have sequence similarity to
Acan125 (Jung et al., 2001). At that time, a CARMIL family
protein was defined as a polypeptide of ⬎1000 aa with a
long LRR domain near the N-terminus and a proline-rich
region capable of binding the SH3 domain of myosin-I (Xu et
al., 1995, 1997; Zot et al., 2000; Jung et al., 2001). In vertebrates, CARMIL genes and proteins have been described in
mice, rats, and humans (Yang et al., 2005; Uruno et al., 2006),
and evidence for three isoforms has been uncovered (Uruno
et al., 2006).
To determine the extent to which different organisms
express CARMIL family members, we searched genome
databases. First, BLAST searches of the human genome using human and mouse forms of CARMIL1 protein, encoded
by genes on human chromosome 6 and mouse chromosome
13, respectively (Yang et al., 2005), identified two additional
human genes, predicted to encode proteins that we refer to
as CARMIL2 and 3. The three predicted proteins are similar
in size and have sequence similarity across their entire
length (Figure 1A).
We cloned cDNAs for human CARMIL1 from HeLa cells
by RT-PCR and obtained a single isoform, which we call
CARMIL1a (described in detail in Materials and Methods).
The GenBank accession number for this cDNA is FJ026014.
CARMIL1a is predicted to contain 1371 aa residues and have
a molecular weight of 151.6 kDa. The gene is LRRC16A,
GeneID 55604, located at chromosome 6p22.2.
Human CARMIL2 is encoded by GeneID 146206 at chromosome 16q22.1. The gene name is RLTPR (RGD motif,
leucine-rich repeats, tropomodulin domain, and proline-rich
containing). The gene was discovered on the basis of its
transcript being down-regulated in the skin of patients with
psoriasis vulgaris (Matsuzaka et al., 2004). That study de5292

scribed sequence similarity to Acanthamoeba CARMIL, expression in all of 30 different tissues examined, and evidence
for alternative splicing in three regions. The principal transcript is predicted to encode a protein of 1436 aa and Mr
154.7 kDa, which we refer to here as CARMIL2a. We cloned
cDNAs for CARMIL2 from HeLa cells by RT-PCR. We found
a single splicing variant, which we call CARMIL2b and
which has GenBank accession number FJ009082. This variant lacks exon 37 and intronic sequence between exons 14
and 15. CARMIL2b is predicted to contain 1372 aa and have
an Mr of 148.2 kDa.
The human gene predicted to encode CARMIL3 is GeneID
90668, named LRRC16B, for “leucine-rich repeat containing
16B” and located at chromosome 14q11.2-q12. The predicted
protein, NP_612369, is 1372 aa with Mr 150.3 kDa.
Next, we searched for CARMIL family proteins across
eukaryotes with BLAST sequence searches. Predicted proteins similar to CARMIL were found encoded in most eukaryotic genomes, including amoebas, nematodes, insects,
fish, birds, and mammals. No genes predicted to encode
CARMIL-like proteins were found in plants or fungi, including Saccharomyces cerevisiae and Schizosaccharomyces pombe.
Phylogenetic tree analysis showed five clusters of sequences
(Figure 1C). CARMIL families 1, 2, and 3 of vertebrates each
defined a cluster, as did the CARMILs of insects. For fish,
well-characterized genomes had single genes for CARMIL,
which clustered with vertebrates. Nematode genomes contained one CARMIL-like protein, which clustered near Acanthamoeba and Dictyostelium CARMIL.
Near their N-terminus, all three of the predicted human
proteins contain a region of high sequence similarity, specific for CARMIL, which we refer to as the CARMIL homology domain (CHD; Figure 1, A and B). Following the CHD,
the proteins contain a conserved LRR region, a verprolinlike sequence, an acidic region, and a C-terminal proline-rich
domain. Within the N-terminal part of the proline-rich region, all three contain a conserved region similar to a region
of mouse CARMIL1 that was shown to be necessary and
sufficient for binding CP (Yang et al., 2005). We refer here to
this region, previously designated C-1 (Yang et al., 2005) or
CAH-3 (Uruno et al., 2006), as the CBR.
CARMIL1 and 3 family members are slightly more similar
to each other than they are to CARMIL2, based primarily on
the CHD (Table 1, Figure 1A). The LRRs, defined by the
consensus sequence LxxLxLxxN/CxxL (Enkhbayar et al.,
2004), are also more similar to those of other CARMILs than
they are to LRRs of non-CARMIL proteins.
Verprolin WH2 domains can bind actin subunits and promote nucleation of polymerization (Paunola et al., 2002).
Alignment of the sequences of CARMIL with WH2 sequences shows some limited sequence similarity (Supplemental Figure S1A), and this includes some of the conserved
residues characteristic of WH2 domains (Chereau et al.,
2005). In WASp family proteins, the WH2 domain combines
with an acidic Arp2/3-binding region to nucleate actin polymerization. The acidic region of Dictyostelium CARMIL is
one continuous region of 72 residues, and that of Acanthamoeba CARMIL is 55 residues; both exhibit strong negative charges (Supplemental Figure S1B). Although the acidic
region of CARMIL2 shows a very strong negative charge,
those of CARMIL1 and 3 are less strongly negative. The
acidic regions of all three human CARMIL proteins are not
continuous, but are made up of two or three short pieces
(Figure 1A). We looked for evidence of interaction of
CARMIL1 with actin or Arp2/3 complex by immunoprecipitation of epitope-tagged CARMIL from HT-1080 cells, but no
such evidence was found (Supplemental Figure S2). This
Molecular Biology of the Cell
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Figure 1. CARMIL protein family sequence and expression analysis. (A) Domain architecture and sequence similarity among human
CARMILs. CHD, CARMIL-homology domain; LRR, leucine-rich repeat; V, verprolin homology; CBR, capping protein-binding region (Bruck
et al., 2006; Canton et al., 2006). (B) Alignment of CHD sequences. Residues identical to the majority in red, and similar ones in blue. (C)
CARMIL family phylogenetic tree. Included proteins possess all three major domains: CHD, LRR, and CBR. Bootstrap analysis showed the
branch points to be significant. Scale bar, the number of amino acid substitutions per site. Sequence accession numbers are in Materials and
Methods. (D) Alignment of CBR sequences, performed as for the CHD sequences of B. (E) Expression of CARMIL and CP-alpha genes in
cultured cells, determined by RT-PCR. Primers are listed in Supplemental Table S1. ␤-Actin was a positive control for loading. For CARMIL1,
the primers flank a region present in CARMIL1a but not CARMIL1b, and the position of the single band is consistent with the predicted size
of 443 base pairs for CARMIL1a. No band is seen at the position of 308 base pairs, predicted for CARMIL1b. For CARMIL2, the primers flank
exon 37, which is present in CARMIL2a but not in CARMIL2b (Matsuzaka et al., 2004). The position of the upper band is consistent with the
predicted size of 592 base pairs for CARMIL2a and that of the lower band with 511 base pairs, predicted for CARMIL2b. HT-1080 cells have
more CARMIL2b than 2a. For the CP alpha subunit, isoforms alpha1 and alpha2 were detected, consistent with previous studies (Hart et al.,
1997).
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Table 1. Sequence similarity among CARMIL family proteins

Acan125
Dicty
Human1a
Human2b
Human3

Dicty

Human1a

Human2b

Human3

Mouse1

Mouse2

Mouse3

33

23
23

21
22
29

24
23
39
33

22
23
90
29
38

13
15
18
86
21

24
23
39
33
95

Percent identity determined with DNASTAR MegAlign and ClustalW.

result, indicating lack of interaction with actin or Arp2/3, is
consistent with previous actin polymerization data for
mouse CARMIL1 (Yang et al., 2005).
The CBR is relatively well conserved among the three
human CARMIL proteins (Figure 1D). The CBR includes a
motif, LxHxTxxRPK, identified as necessary for binding to
CP in previous studies with CARMIL1, CD2AP, and CKIP-1;
the latter two are otherwise unrelated to CARMIL (Bruck et
al., 2006; Canton et al., 2006; Uruno et al., 2006). The CBR is
located within a long proline-rich region at the C-terminus
of the three human CARMIL proteins. In a separate study,
we examined the role of CP-binding by CARMIL (Liang, Y.,
Kim, T., Niederstrasser, H., Edwards, M., Jackson, C. E.,
Butler, B., and Cooper, J. A., unpublished data). Purified
CARMIL2 CBR had biochemical activities similar to those of
CARMIL1, in that it bound CP, prevented capping, and
caused uncapping.
The C-terminal region of Dictyostelium and Acanthamoeba
CARMIL is able to bind the SH3 domain of certain class-I
myosins (Xu et al., 1997; Jung et al., 2001). We found that
human CARMIL1a can bind to myosin 1E, an SH3-containing form of myosin 1 in humans (Krendel et al., 2007).
Anti-Flag antibodies precipitated endogenous myosin 1E
from lysates of HT-1080 cells expressing Flag-tagged
CARMIL1 but not CARMIL2 (Supplemental Figure S2).
To determine the expression profile of the three CARMIL
genes in cultured cell lines, RT-PCR was performed.
CARMIL1 and 2 were expressed in all the cell lines tested
(Figure 1E). For CARMIL1 and 2, we chose PCR primers
designed to detect the splice forms mentioned above. For
CARMIL1, we detected CARMIL1a, the form that we cloned
(NCBI FJ026014), but not CARMIL1b (NCBI NM_017640).
Differences between CARMIL1a and 1b are described further in Materials and Methods section. For CARMIL2, the sizes
of the PCR products were consistent with alternative splicing described previously (Matsuzaka et al., 2004). The major
band corresponded to CARMIL2b, the cDNA that we cloned
above and use for expression below. CARMIL3 expression
was more restricted, detected primarily in immune cells
(Figure 1E). In this study, to address the role of CARMIL in
cell migration, we chose the human fibrosarcoma cell line
HT-1080. Therefore, based on the expression results, we
examined the functions of CARMIL1 and 2, but not
CARMIL3, in the HT-1080 cells.
Distinct Roles for CARMIL1 and 2 in Cell Migration and
Spreading
To test the roles of CARMIL1 and 2 in cell migration, isoformspecific shRNA-expression plasmids, called CARMIL1i and 2i,
were constructed. Their efficacy and specificity were tested in
HT-1080 and HEK293 cells expressing yellow fluorescent protein (YFP) fusions of CARMIL1 or 2 (Supplemental Figure S3).
Each shRNA successfully lowered the level of its target protein
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isoform without affecting the level of the other isoform. As a
negative control, a scrambled shRNA sequence had little to no
effect on the level of either isoform. In addition, CARMIL1i
decreased the level of endogenous CARMIL1 protein in HT1080 cells (Figure 2A), and CARMIL2i decreased the level of
endogenous CARMIL2 RNA in HT-1080 cells (Figure 2B).
To assess the effect of CARMIL knockdown on cell migration, a scratch wound-healing assay was performed with
HT-1080 cells and time-lapse video microscopy. This human
fibrosarcoma cell line grows as a monolayer, and cells migrate rapidly to fill wounds. Based on time-lapse movies,
cells expressing either CARMIL1i or 2i shRNA filled the
wound gap more slowly than did control scramble-expressing cells (Figure 2C, Movies 1–3). In CARMIL1 knockdown
cells at the wound edge, the movies revealed decreases in
lamellipodia, ruflling, and macropinosomes, compared with
control cells. In CARMIL2 knockdown cells, the leading
edge was smooth and flat, with no ruffles or macropinosomes. Also, the leading edge changed direction over time.
To quantitate the results from the wound-healing assay in
another way, we calculated cell speed by tracking the displacements of individual cell nuclei over time, from each
frame to the next (Figure 2D). The average speed of
CARMIL1i cells was greatly decreased (to 29% of control),
and the average speed of CARMIL2i cells was also decreased (to 52% of control), by a smaller amount. Both
differences were highly statistically significant.
To investigate why depletion of CARMIL1 or 2 impaired
cell migration in wound healing, we next examined the
actin-rich leading edge of single cells. HT-1080 cells have
prominent lamellipodia and filopodia, which are highly dynamic. Cells were cotransfected with an shRNA-knockdown
plasmid and an RFP expression plasmid, in order to identify
transfected cells and compare them with nontransfected
cells. The RFP fluorescence provided a sense of the level of
transfection for each cell, allowing one to compare low,
medium, and high expressors. This approach provided
some indication of whether effects were primary versus
secondary, when multiple effects were observed. Time-lapse
phase-contrast movies of living cells were collected, and
cells were fixed and stained with fluorescent phalloidin to
visualize filamentous actin.
In the phalloidin-stained fixed-cell images, control cells
were well polarized with multiple lamellipodia at a single
broad leading edge (Figure 3A.) Actin filament bundles,
which might be called filopodia or microspikes depending
on their protrusion length, were embedded in the lamellipodia (Figure 3A). Cells displayed tail retraction at the trailing edge. This overall morphology, which we refer to as
unipolar, was seen in 83 ⫾ 0.9% of cells expressing scrambled shRNA (n ⫽ 576, Figure 3B).
In CARMIL1 knockdown cells, the shape of the cell outline was properly polarized (Figure 3, A and B, 86 ⫾ 1.5% of
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Figure 2. Knockdown of CARMIL1 or 2 inhibits cell migration during wound healing. (A)
Knockdown of endogenous CARMIL1 protein. HT-1080 cells were transfected with
vector, scrambled shRNA or shRNA targeting CARMIL1. Immunoblots of whole cell
lysates were probed with anti-CARMIL1, as
well as anti-CP and anti-actin. (B) Knockdown of endogenous CARMIL2 RNA. Cells
were treated as in A, except with shRNA
targeting CARMIL2, and RT-PCR was performed to assess the level of RNA expression. Serial twofold dilutions of the control
RNA sample showed that the level of knockdown was between two- and fourfold (data not
shown). (C) Cell migration during wound healing, monitored by time-lapse phase-contrast
microscopy of HT-1080 cells. Images are frames
from Movies 1–3. A monolayer of HT-1080
cells expressing scrambled, CARMIL1i, or
CARMIL2 shRNA was scratched 3 d after
transfection. Yellow lines show the boundary of the wound, the white arrow points in
the direction of cell migration, and black
arrowheads indicate protrusions and ruffles
at the leading edge of cells. (D) Cell speed
comparison, based on tracking nuclear position from frame to frame in time-lapse
movies. At least 15 cells from two to three
independent experiments were analyzed
using Image J (http://rsb.info.nih.gov/ij/). Results plotted are mean and SEM; **p ⬍0.001 and ***p ⬍ 0.0001.

cells, n ⫽ 649), but the intensity of lamellipodial staining by
phalloidin was greatly decreased, as illustrated by representative images (Figure 3A). Quantitation of the intensity of
staining at the leading edge confirmed that the staining
intensity was less, and the curve of intensity versus position
was flat, lacking a peak behind the leading edge (Figure 3C).
Actin filament bundles resembling short stress fibers were
scattered about the cytoplasm (Figure 3A).
The CARMIL2 knockdown cells exhibited phenotypes
distinct from those of CARMIL1i cells. Many CARMIL2i
cells (44 ⫾ 17%, n ⫽ 563) displayed a multipolar morphology, with lamellipodia at several locations on the cortex
(Figure 3, A, B, and D). A substantial fraction (20 ⫾ 7%) of
CARMIL2i cells had apolar shapes without a distinguishable
leading edge or retracting tail (Figure 3B), and only 17 ⫾ 7%
of cells had a unipolar shape (Figure 3B). At high magnification, some CARMIL2i lamellipodia were relatively normal, with actin bundles in lamellipodia (Figure 3A), whereas
others had decreased lamellipodial actin staining and lacked
lamellipodial bundles (Figure 3A). In the quantitation of
actin staining at the leading edge (Figure 3C), CARMIL2i
cells showed an overall moderate decrease of staining intensity, but the shape of the intensity versus position curve was
similar to that of control cells, in contrast to the result for
CARMIL1i cells. CARMIL2i cells did not show increased
stress fiber-like structures, also in contrast to CARMIL1i
cells. Off-target silencing was excluded by rescue expression
with RNAi-resistant forms of CARMIL1 or 2, discussed further below in the context of cross-rescue. Thus, CARMIL1
appeared to be required for the assembly of lamellipodial
actin, and CARMIL2 appeared necessary primarily for cell
polarity, with some contribution to lamellipodial actin assembly.
We followed these observation of fixed cells with movies
of living cells migrating on a fibronectin-coated surface.
Again, cells were plated at low density to allow observations
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of individual cells (Figure 3D, Movies 4 –7). To quantitate
effects objectively, “blind” observers of the movies scored
defined parameters. In terms of cell polarity, control scrambled-shRNA cells remained well polarized, with a unipolar
shape, for 2 h (89%, 16/18, Figure 3D). During this time, cells
moved and changed direction; this was accomplished by
retracting existing lamellipodia and extending new lamellipodia in a concerted manner (Figure 3D, Movie 4). Characteristically, new lamellipodia showed prominent ruffling,
which led to the formation of phase-bright macropinosomes.
For CARMIL1 knockdown cells, the unipolar morphology
was maintained (86%, 12/14, Figure 3B); however, lamellipodia and peripheral ruffles were less frequent, short-lived,
or not formed at all, whereas macropinosomes were rarely
seen (Figure 3D, Movie 5). In contrast, CARMIL2 knockdown cells exhibited with multiple leading edges and frequent changes in directions; individual lamellipodia appeared to pull the cell in different directions (76% of cells,
16/21; Figure 3D, Movies 6 and 7). Some of these leading
edges ultimately became long tails. At the leading edge,
some CARMIL2 knockdown cells had regions deficient in
lamellipodia formation, membrane ruffling, and macropinosome formation.
To compare the effects on lamellipodia in CARMIL1
knockdown versus CARMIL2 knockdown cells in detail, we
viewed the leading edge at high magnification with high
time resolution (Figure 4A). Control scrambled cells exhibited cycles of protrusion and withdrawal, accompanied by
ruffling and macropinosome formation (Figure 4A, Movie
8). At the leading edge of CARMIL1i cells, membrane protrusions were smaller and extended more slowly and less
frequently over time (Figure 4A, Movie 9). Ruffles were
small and infrequent, and no macropinosomes appeared to
form. Focusing on the abnormal lamellipodial regions of
CARMIL2i cells, we saw persistent protrusions at the lead5295
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Figure 3. Differential effects of CARMIL1 versus CARMIL2 knockdown on lamellipodium formation and cell polarity in HT-1080 cells. (A)
Effects on lamellipodia revealed by fluorescence images of cells stained with coumarin-phalloidin. Lamellipodial regions are enlarged in
insets. Arrowheads point to the leading edge of migrating cells. An RFP expression plasmid was cotransfected to identify transfected cells.
Scale bar, 20 m on all panels. (B) Scoring of the degree of polarity in cells, as a percentage of total cells. Polarity scored by blind observers
as described (Sidani et al., 2007). n ⫽ ⬎300 cells per group. Results plotted are mean and SEM from three experiments. Representative cells
are shown. (C) Profile of fluorescent phalloidin intensity at the cell edge. The average fluorescence pixel intensity at each distance from the
cell edge was determined by an Image J macro as described (Cai et al., 2007). The values were normalized to the highest value of the scrambled
group. *p ⬍ 0.05 and **p ⬍ 0.001. n ⫽ ⬎14 cells per group. (D) Effects on cell polarity revealed by time-lapse phase-contrast images, in frames
from Movies 4 –7. Black arrowheads indicate the leading edge of migrating cells, white arrowheads indicate sites of constriction, and white
arrows indicate macropinosomes.

ing edges, but they were smooth, slow and free of ruffles and
macropinosomes (Figure 4A, Movie 10).
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To gain additional insight into the roles of CARMIL1 and
2, we examined how individual cells spread on a surface,
Molecular Biology of the Cell
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Figure 4. Effects of CARMIL1 versus 2 knockdown on lamellipodial dynamics and cell
spreading. (A) Lamellipodial dynamics in
frames from phase-contrast time-lapse Movies
8 –10. Arrowheads indicate the cell edge. Scale
bar, 20 m. (B) Cell spreading, in frames from
phase-contrast time-lapse Movies 11–13. White
arrowheads, lamellipodia with features described in the text.

with time-lapse movies, with observations scored by blind
observers (Figure 4B, Table 2, Movies 11–13). Control scrambled cells extended and retracted membrane protrusions,
with prominent ruffling, all along the cell perimeter (Figure
4B, inset, Movie 11). At ⬃18 min, cells became polarized
with a major lamellipodial protrusion on one side of the cell
and retraction fibers on the other side (Table 2). This mor-

phology persisted until the end of the 30-min movie, with
few cells (14%) changing direction. In CARMIL1 knockdown
cells, cells initially spread well, with intense ruffling. However, after ⬃10 min, the edge of most cells (75%) consisted of
aberrant structures that were small, phase-dark, and shaped
like blebs or fingers (Figure 4B, inset, Movie 12). CARMIL1i
cells became polarized at 17 min and did not change

Table 2. Effect of CARMIL knockdown on cell spreading

Scrambled
CARMIL1i
CARMIL2i

Maintenance of
protrusion/retraction
(% of cells)

Change of direction
(% of cells)

Smooth edge
without ruffles
(% of cells)

Appearance of
retraction
fibers (min)

Onset of
polarization (min)

No. of
cells

100
25
13

14
13
63

0
0
75

18.3 ⫾ 1.9
17.4 ⫾ 1.8
12.8 ⫾ 2.0

18.3 ⫾ 1.9
17.4 ⫾ 1.8
21.5 ⫾ 3.7

7
8
8

Time-lapse phase-contrast microscope movies of living cells were observed. Cells that maintained protrusion and retraction of lamellipodia
over a 30-min time course were scored, as were cells that changed the direction of their protrusions. The times when retraction fibers
appeared and polarization began were determined. Values are mean ⫾ SEM.
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direction, similar to control cells (Table 2). Spreading of
CARMIL2 knockdown cells differed from that of control
or CARMIL1i cells (Figure 4B, inset, Table 2, Movie 13). As
CARMIL2i cells spread, the cell edge was smooth without
ruffles. Retraction fibers appeared early, and the cells did not
adopt a well-polarized shape until late. Moreover, most cells
changed direction. Thus, consistent with the observations on
migrating cells, spreading CARMIL2i cells showed decreased protrusion/retraction activity, impaired ruffle formation, and disrupted polarity.

Effects of CARMIL1 on Lamellipodial Actin
To understand more fully the role of CARMIL1 in lamellipodia formation and dynamics, we localized molecular
markers and free barbed ends in the cells. For free barbed
ends, we used a permeabilized-cell in situ assay (Symons
and Mitchison, 1991; Bryce et al., 2005). We found incorporation of fluorescent actin at the leading edge, reflecting the
number of free barbed ends, to be much less in CARMIL1
knockdown cells than in control scrambled cells (Figure 5A).
We stained cells with antibodies against Arp2/3, cortactin

Figure 5. Effect of CARMIL1 knockdown on
molecular markers and GTP-Rac1 activity. (A)
Free barbed ends of actin filaments, assessed by
incorporation of fluorescent actin in permeabilized cells. Scale bar, 20 m on all panels. (B and
C) Cells stained with antibodies to Arp2/3, cortactin, or VASP and costained with coumarinphalloidin. Asterisks indicate transfected cells.
Arrows in C indicate tips of filopodia. (D) Levels of GTP-Rac1 activity in cells spreading on
fibronectin, over time in minutes. GTP-Rac1
was pulled down with PAK-PBD, and precipitates were analyzed by immunoblot.
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and VASP, proteins that function at the leading edge to
control lamellipodial architecture and dynamics (Bear et al.,
2002). CARMIL1 knockdown cells showed decreased
Arp2/3 and cortactin staining at the leading edge (Figure
5B). VASP staining was enriched at the leading edge in
control cells, especially at tips of actin filament bundles
(Figure 5C). In CARMIL1 knockdown cells, the intensity of
VASP staining at the leading edge was greatly decreased.
Taken together, these results show that the loss of CARMIL1
leads to a decrease of each of all the molecular components
of lamellipodia that were examined. In contrast, knockdown
of CARMIL2 often had little to no effect on Arp2/3 and
cortactin staining at the leading edge, as described more
fully below (see Figure 7B and data not shown).
To gain insight into the molecular mechanism of CARMIL
action in lamellipodia formation, we measured the activation of Rac1 over time in spreading cells (Figure 5D). In
control scrambled and CARMIL2i cells, the level of active
Rac1 was increased at 15 and 30 min. In contrast, in
CARMIL1i cells, the level of active Rac1 did not change. A
recent study in C. elegans found biochemical and genetic
interactions between CARMIL and Trio/UNC-73, a large
protein with both Rac- and Rho-GEF domains (Vanderzalm
et al., 2009). We looked for a biochemical interaction between
CARMILs and Trio in our cells, by coimmunoprecipitation.
We observed coprecipitation of human Trio with CARMIL1,
but not with CARMIL2 (Supplemental Figure S2).
Overall, these results indicate that CARMIL1 contributes
to the dendritic actin network assembly of lamellipodia and
ruffles, apparently upstream of Rac1 with the possible involvement of Trio. CARMIL2 appears to have some role in
lamellipodial actin assembly, but the role appears to be
smaller and less important than that of CARMIL1.

Effects of CARMIL2 on Cell Polarity: Microtubules and
Myosin-II
Cell polarity, including the polarity of migrating cells, often
involves the position of the microtubules and the microtubule-organizing center (MTOC; Gomes et al., 2005; Siegrist
and Doe, 2007). Because loss of CARMIL2 conferred an
apparent multipolar phenotype, we examined cell polarity.
First, we asked whether the orientation of the microtubule
cytoskeleton was affected. Cells were costained with antibodies against microtubules and the Golgi complex, which
often colocalizes with the MTOC. Control scrambled cells
displayed a unipolar morphology, with microtubules and
the Golgi located between the nucleus and the leading edge
(Figure 6, A and B.) CARMIL2 knockdown cells showed
poor polarity, with the MTOC and Golgi situated either
behind the nucleus or off to one side, but not in the direction
of the leading edge (Figure 6, A and B). ␥-Tubulin, which
marks the MTOC, and acetylated tubulin, which marks stable microtubules, were present but not polarized properly
(Figure 6C). In contrast to CARMIL2, CARMIL1 knockdown
cells showed a well-polarized microtubule morphology, indistinguishable from control scrambled cells (Figure 6B and
data not shown).
Examining the interface between the microtubule cytoskeleton and the leading edge at high magnification, many
distal ends of microtubules appeared to contact the actinrich lamellipodium in control cells (Figure 6A, inset). In
CARMIL2 knockdown cells, the density of microtubule ends
was less. Also, as noted above, bundles of actin filaments
were absent in the lamellipodial actin.
Conventional class-II myosin has been implicated in cell
polarity during cell migration, and migrating fibroblasts

Figure 6. Effect of CARMIL2 knockdown on polarity in migrating cells. (A) Fluorescence images of CARMIL2 knockdown cells stained for
giantin of the Golgi complex and for microtubules. GFP-actin is a transfection marker. Arrows indicate the MTOC/Golgi. Insets show the
relationship of microtubules with actin at the cell cortex. (B) MTOC polarization scored from images like those in A. Data are plotted as
percent of cells ⫾ SE of proportion; n ⫽ ⬎100 cells per sample. (C) Cells stained with fluorescent antibodies for acetylated tubulin and
␥-tubulin. Arrowheads indicate the centrosome. Scale bar, 20 m.
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Figure 7. Effect of CARMIL knockdown on
Myosin-II. (A) Cells stained with anti-Myosin-IIA heavy chain and anti-paxillin Abs. Arrowheads, lamellipodia structures; arrows,
focal adhesions. GFP-actin is a transfection
marker. (B) Cells stained with anti-MyosinIIB heavy chain and anti-Cortactin Abs. Arrows, Myosin-IIB localization; arrowheads,
the leading edge of cells. Scale bar, 20 m. (C)
Expression of Myosin-II heavy chain isoforms
in cells, analyzed by immunoblot.

express two of the three genes for myosin-II, A and B (Lo et
al., 2004; Vicente-Manzanares et al., 2007). To examine the
role of myosin-II in cells lacking CARMIL, we stained cells
with antibodies to myosin-IIA and myosin-IIB. Costaining
with antibodies to paxillin and cortactin provided markers
for focal adhesions and lamellipodial actin, respectively. In
control cells, myosin-IIA and -IIB were mainly concentrated
in the central part of the cell, with little to no staining of the
leading edge (Figure 7, A and B), consistent with previous
findings (Vicente-Manzanares et al., 2007).
In CARMIL2 knockdown cells, the most notable change was
a decrease in the overall intensity of staining for myosin-IIB
(Figure 7B), with no apparent change in the intensity of myosin-IIA staining (Figure 7A). These results were confirmed by
immunoblots (Figure 7C). In addition, in CARMIL2 knockdown cells, the anti-paxillin-stained focal adhesions were more
numerous and less intense (Figure 7A). For CARMIL1 knockdown cells, the staining intensity for myosin-IIA and -IIB was
relatively normal, confirmed by immunoblot (Figure 7C). The
number and staining intensity of stress-fiber-like structures
was increased, consistent with the phalloidin staining described above (Figures 3A and 5), and the intensity of antipaxillin staining at the ends of the stress fibers was increased.
Thus, the polarity defect of CARMIL2-deficient cells is
accompanied by defects in the microtubule cytoskeleton and
5300

myosin-II, none of which have been previously implicated in
the function of CARMIL.
Localization of CARMIL1 and 2
To gain further insight into the roles of CARMIL1 and 2 in
cell migration, we performed subcellular localization studies. We localized YFP-fusions of full-length CARMIL1 and 2,
expressed at low level (Figure 8, A and B; see Materials and
Methods for details of the cDNAs used). Endogenous
CARMIL1 and 2 were difficult to visualize by immunofluorescence because of weak staining. In a parallel study, we
documented the functionality of these YFP fusions (Liang,
Y., Kim, T., Niederstrasser, H., Edwards, M., Jackson, C. E.,
Butler, B., and Cooper, J. A., unpublished data). Each fusion
rescued shRNA-knockdown phenotypes fully, based on
qualitative and quantitative assays of their characteristic
traits, and each fusion immunoprecipitated endogenous CP.
For YFP-CARMIL1, fluorescence was enriched at the
leading edge of migrating HT-1080 cells (Figure 8, A and
B), consistent with its role in lamellipodial formation.
Similar results were obtained with migrating SNB-19 and
B16-F1 cells (Supplemental Figure S4), consistent with
previous findings (Yang et al., 2005). As a negative control,
YFP alone was evenly distributed throughout the cytoplasm (Figure 8A).
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Figure 8. Localization of CARMIL1 and 2. (A) HT-1080 cells expressing YFP, YFP-CARMIL1, or YFP-CARMIL2, stained with phalloidin-coumarin. Scale bar, 20 m. (B) Cells cotransfected with
RFP-CARMIL1 and YFP-CARMIL2 and then stained with anticortactin Abs. Arrowheads indicate areas of the leading edge where
CARMIL1 and 2 localizations differ. Merge includes RFP-CARMIL1
and YFP-CARMIL2. (C) Sequential images of live cells expressing
YFP-CARMIL1 or YFP-CARMIL2. Arrowheads point to macropinosome formation. Boxed regions are enlarged to show the detail. See
Movies 14 –15.

Migrating HT1080 cells often form macropinosomes
(Figures 2C and 3D). We found that YFP-CARMIL1 was
enriched in newly formed macropinosomes (Figure 8C,
Movie 14), as previously reported for Dictyostelium (Jung
et al., 2001). The association of CARMIL1 macropinosomes
was transient, disappearing as the vesicles moved into
the cell (Movie 14). Taken together, the localization of
CARMIL1 to lamellipodia and macropinosomes confirms
Vol. 20, December 15, 2009

its role in actin assembly dynamics at the plasma membrane.
To investigate how CARMIL1 was recruited to the leading
edge, we depleted Arp2/3 complex by siRNA knockdown
of the p20 subunit (Supplemental Figure S5, A and B).
YFP-CARMIL1 localization was lost, along with the cortactin and phalloidin staining characteristic of lamellipodial
actin (Supplemental Figure S5, B and C). In contrast, in a
concurrent set of experiments described in another study,
depletion of CP, which enhances actin polymerization at the
leading edge, did not impair YFP-CARMIL1 localization
there (Liang, Y., Kim, T., Niederstrasser, H., Edwards, M.,
Jackson, C. E., Butler, B., and Cooper, J. A., unpublished
data). Thus, CARMIL1 appears to be recruited to lamellipodia and to be important for their formation, suggesting its
participation in a positive feedback cycle.
In contrast, YFP-CARMIL2 fluorescence was not concentrated at the actin-rich leading edge (Figure 8A) or at macropinosomes (Figure 8C, Movie 15). This difference was seen most
clearly in a direct comparison of RFP-CARMIL1 with YFPCARMIL2 in doubly transfected cells (Figure 8B). Instead, most
CARMIL2 fluorescence was distributed throughout the cytoplasm in a coarse fibrillar pattern reminiscent of intermediate
filaments (Figure 8A). Indeed, staining of YFP-CARMIL2 cells
with antibodies to vimentin revealed extensive colocalization
(Figure 9A and Supplemental Figure S6A). Treatment of these
cells with WFA, a specific inhibitor of vimentin filament assembly (Bargagna-Mohan et al., 2007), led to collapse of the
vimentin filament network, with relatively little effect on microtubules or actin. YFP-CARMIL2 colocalized with the collapsed vimentin filaments (Figure 9A). The effect of WFA on
vimentin and CARMIL2 depended on the concentration and
time of WFA treatment.
Vimentin intermediate filaments are also known to collapse toward the nucleus when microtubules are depolymerized, based on a dynamic association between the two
filament systems (Gurland and Gundersen, 1995; Ho et al.,
1998). In our cells, nocodazole treatment completely depolymerized microtubules and also caused the vimentin intermediate filaments to collapse (Supplemental Figure S6B).
The distribution of YFP-CARMIL2 mirrored that of vimentin, during nocodazole treatment and washout.
In addition, we examined the localization of CARMIL2 in
vimentin-depleted cells, using shRNA to knock down vimentin. Vimentin depletion was nearly complete (Figure 9,
B and C). In the absence of vimentin, CARMIL2 had a diffuse
pattern, not a fibrillar one (Figure 9C). Conversely, we examined the distribution of vimentin in CARMIL2 knockdown cells, by immunofluorescence staining, and we observed no gross effects (data not shown).
We investigated the specificity of the association of CARMIL2 with vimentin by localizing CARMIL2 in the A549 cell
line, which expresses both vimentin and keratin intermediate
filament proteins. Vimentin and keratin staining showed distinct patterns, and the pattern of CARMIL2 localization was
similar to that of vimentin and different from that of keratin
(Figure 9D). Moreover, the collapse of vimentin induced by
WFA in these cells caused a collapse of CARMIL2 staining with
little effect on the distribution of keratin (Figure 9D). Thus,
CARMIL2 appears to have a specific association with vimentin
intermediate filaments, which has not been reported for any
CARMIL protein.
Failure of Cross-Rescue between CARMIL1 and 2
To address directly the question of overlapping versus distinct functions for CARMIL1 and 2, we asked whether expression of one isoform was able to rescue or suppress the
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Figure 9. CARMIL2 colocalization with vimentin filaments. (A) Cells were treated with
withaferin A (WFA) under conditions chosen
for maximal collapse of vimentin filaments
with minimal effects on microtubules. Fixed
cells were stained for vimentin, microtubules,
and filamentous actin. Scale bar, 20 m. (B)
Efficacy of vimentin knockdown determined
by immunoblot. (C) Effects of vimentin
knockdown on CARMIL2 localization. Control scrambled and vimentin-knockdown cells
were cotransfected with YFP-CARMIL2 and
stained with anti-vimentin antibody. Scale
bar, 20 m. (D) Fluorescence images showing
colocalization of YFP-CARMIL2 with vimentin but not keratin in A549 cells. Control and
WFA-treated cells are shown.

knockdown phenotypes of the other. Using shRNA plasmids, we knocked down each isoform and then expressed an
RNAi-resistant cDNA, constructed as a YFP-CARMIL fusion, which allowed us to identify transfected cells and
assess the relative level of expression. In control experiments
in a parallel study (Liang, Y., Kim, T., Niederstrasser, H.,
Edwards, M., Jackson, C. E., Butler, B., and Cooper, J. A.,
unpublished data), wild-type CARMIL1 expression rescued
CARMIL1 knockdown phenotypes, and wild-type CARMIL2
rescued CARMIL2 knockdown phenotypes. Here, neither
isoform was able to rescue the knockdown of the other one
in any noticeable manner (Figure 10), showing that the
cellular functions of CARMIL1 and 2 are distinct.
Overexpression
To gain further insight into the functions of CARMILs, we
asked how overexpression of CARMILs might affect cell
motility and cell migration by expressing YFP-CARMIL fusions in otherwise normal HT-1080 cells, which had normal
levels of endogenous CARMILs. First, we observed that
YFP-CARMIL1 expression caused alterations in lamellipodia (Figure 8A, Supplemental Figure S7; Liang, Y., Kim, T.,
Niederstrasser, H., Edwards, M., Jackson, C. E., Butler, B.,
and Cooper, J. A., unpublished data). At low expression
levels, the intensity of phalloidin staining in the lamellipo5302

dium was slightly decreased. At higher expression levels,
normal lamellipodia were not seen; instead, abnormal small,
contorted protrusions were present. Movies (not shown)
confirmed that these structures were protrusions and not the
end-product of retractions. With further increases in the expression levels of YFP-CARMIL1, the leading edge adopted an
irregular shape, with long narrow protrusions, rather than the
single broad sheet seen normally. These irregular protrusions
contained Arp2/3, CP, and cortactin along their periphery, by
immunofluorescence (Supplemental Figure S7). In contrast,
VASP was not detected at the tips of these structures. Thus,
these protrusions appear to be abnormal forms of lamellipodia,
not filopodia.
For CARMIL2, expression of YFP-CARMIL2 did not result
in a detectable effect on the shape of the cell or the distribution of cytoskeletal filaments, including vimentin intermediate filaments, microtubules or actin, even at high levels of
expression (Figures 8A and 9A, Supplemental Figure S6, A
and B, and data not shown).
DISCUSSION
The most important conclusions from our study relate to the
function of CARMIL in cells. First, the CARMIL1 and 2
isoforms have distinct functions, consistent with their conMolecular Biology of the Cell
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Figure 10. Cross-rescue expression analysis. CARMIL1 knockdown cells expressing CARMIL2, and vice versa. Cells are stained
with coumarin-phalloidin. The characteristic phenotypes were not
rescued in either case. In controls, each expression plasmid rescues
its own knockdown phenotypes (Liang et al., 2009).

servation across vertebrates. Second, CARMIL2 is necessary
for cell polarity, a novel finding for a CARMIL family protein, and CARMIL2 is associated with vimentin filaments.
The conclusion that CARMIL1 and 2 have distinct functions is based on observations of different knockdown phenotypes, protein localizations, and overexpression phenotypes. Furthermore, expression of CARMIL2 did not rescue
knockdown phenotypes of CARMIL1-deficient cells and
vice versa. In addition, we found that CARMIL1 homodimerized with itself, as Acanthamoeba CARMIL does
(Remmert et al., 2004), but CARMIL1 did not heterodimerize
with CARMIL2, based on immunoprecipitation with pairs of
different epitope tags (data not shown).
Phylogenetic analysis revealed conserved CARMIL-encoding genes in a wide variety of metazoans, including
insects and amoebae. Most interesting, we found that vertebrates have three conserved isoforms of CARMIL, expressed
from different genes. On this basis alone, one might expect
CARMILs to have distinct roles in animal cells.
As cell migration is a defining feature of animals, we
focused our studies of CARMIL function on cell migration,
using predominantly the human fibrosarcoma cell line HT1080. We found that these cells and most other cell lines
express CARMIL1 and 2, and we cloned full-length cDNAs
to avoid relying on genome-based predictions. CARMIL3
showed very low expression in HT-1080 cells and in most
Vol. 20, December 15, 2009

cells and tissues, so we did not include it in this analysis.
CARMIL3 appears to be expressed in immune and other
hematopoietic cells, where its function remains to be explored.
For CARMIL1, our results show that it functions in lamellipodia in the control of actin assembly, consistent with
previous studies in Dictyostelium and cultured human cells
(Jung et al., 2001; Yang et al., 2005). We found that CARMIL1
localized to lamellipodia, and that RNAi-mediated knockdown of CARMIL1 led to inhibition of lamellipodial actin
assembly. Expression of CARMIL1 at low levels over the
endogenous level also caused inhibition of lamellipodial
actin. At high levels of expression, CARMIL1 caused extreme distortion of lamellipodial structures. Together, the
results suggest a complex nonlinear role for CARMIL. In
CARMIL1 knockdown cells, Rac1 activity was decreased,
consistent with inhibition of lamellipodia. In addition, we
found that CARMIL1 associates with the Rac-GEF Trio, as
recently observed in C. elegans (Vanderzalm et al., 2009).
Thus, CARMIL1 may control lamellipodial actin assembly
via effects on Trio and Rac1.
For CARMIL2, one might have hypothesized a priori
that it would function in a manner similar to CARMIL1,
being a closely related isoform. This was not the case.
First, CARMIL2 localized to vimentin intermediate filaments, not to lamellipodia or the leading edge. This conclusion is based on knocking down vimentin and on treatment
with a vimentin pharmacologic inhibitor, WFA. In addition,
in cells expressing both keratin and vimentin, CARMIL2
colocalized with vimentin but not keratin filaments, providing evidence for specificity.
Second, cells depleted of CARMIL2, by RNAi knockdown,
showed a distinctive multipolar phenotype not observed in
CARMIL1 knockdown cells. Snapshots of migrating cells
showed that one cell would often have two to four leading
edges, and movies showed that the multiple leading edges
would form, move forward, and disassemble with no apparent coordination. In particular, the knockdown cells
seemed to suffer from the inability to disassemble or suppress the minor leading edges, and cells often stretched
themselves thin as their different parts attempted to walk
away from each other. Sometimes, the leading edges
showed flat and smooth protrusions, with decreased actin
and little ruffling or macropinocytosis, whereas sometimes
the leading edges were relatively normal. These effects may
be a consequence of having multiple leading edges; actin
assembly is a cooperative process, so its occurrence at one
location might decrease the availability of subunits for assembly at some of them.
How might a protein associated with vimentin intermediate filaments affect cell migration? In previous studies, the
cellular level of vimentin was found to be proportional to
the ability of cells to migrate, based on expression, antisense
and knockout approaches (Eckes et al., 1998; Gilles et al.,
1999). Microtubules and myosin-II are both important for
cell migration (Gomes et al., 2005). Here, we observed the
microtubule cytoskeleton to be improperly polarized and
myosin-IIB levels to be decreased in CARMIL2-knockdown
cells. In a previous study, the phenotype of embryonic
fibroblasts from myosin-IIB knockout mice included evidence for multipolarity (Lo et al., 2004), reminiscent of the
CARMIL2- knockdown phenotype here. The molecule basis
of the connections between CARMIL2, vimentin, and myosin-IIB remain to be explored.
In addition, we found that vimentin filaments depend on
microtubules for assembly, but not vice versa, based on
pharmacologic inhibitor results, consistent with previous
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studies (Shohat et al., 1976a,b; Gurland and Gundersen,
1995). However, we found that simple drug treatments
alone, affecting either microtubules or vimentin, did not
cause the cells to become multipolar in the manner seen with
loss of CARMIL2. Multiple previous studies have found that
vimentin filament assembly depends on microtubules, but
there has been little evidence for the converse (Gyoeva and
Gelfand, 1991; Chou et al., 2007; Shim et al., 2008). In one
study, inhibition of vimentin assembly decreased the formation of cell “microtentacles,” which contain microtubules
(Whipple et al., 2008). On the other hand, in many cell
systems complete collapse of vimentin intermediate filaments has had no effect on microtubules (Klymkowsky,
1981, 1983; Lin and Feramisco, 1981; Gyoeva and Gelfand,
1991). To understand how CARMIL2 may link vimentin
filaments with other elements of the cytoskeleton and cell
polarity will require further study.
The molecular phylogeny of CARMILs shows conservation in multiple domains of this large protein, raising the
possibility of multiple interactions and functions. Initial
studies with amoeba CARMILs suggesting binding to CP,
Arp2/3, actin, and myosin-I as potential bases of function.
Previous work with the CARMIL1 isoform of vertebrates
suggested a role in lamellipodial actin assembly (Yang et al.,
2005). Our results here confirm that idea and show that the
function of the CARMIL2 isoform, also expressed in migrating cells, is distinct. Further work will be required to identify
the molecular basis of action of the CARMIL isoforms. Our
identification here of the high conservation of CHD focuses
attention on this region, to be considered with the multiple
other regions defined previously by sequence analysis and
biochemical studies. In addition, one other feature shared by
the two isoforms is that both interact with some form of
myosin: CARMIL1 with myosin-IE and CARMIL2 with myosin-IIB.
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